In recent years, it has become clear that the impact of epigenetics is more common and complex than previously suspected, underscoring the need to conduct in-depth studies of these mechanisms.
Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with...
The formulation, indication and dosages of Trintellix remain the same as that of Brintellix.
Allergan is the first company to launch a generic version of of this drug to customers in the U.S.
The swift response came hours after Paris-based Sanofi, France's biggest drugmaker, threatened Medivation's board members with possible removal if they won't discuss a deal.
More than 15 million Americans have prescriptions for so-called proton pump inhibitors (PPIs), which decrease gastric acid production and generally have been considered safe.
The new grant will enable Disney and his team to further investigate the manipulation of microRNAs.
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection.
Lilly has received additional designations for olaratumab from the FDA.
Metformin's action is generally related to the release of glucose from the liver.
Scientists are trying to find new ways to produce the nutritional fatty acids.
Multiple myeloma affects more than 30,000 Americans each year and is slightly more prevalent in men than in women.
The therapy has the ability to cross the blood-brain barrier and directly targets motor neurons affected by SMARD1.
New federal rules announced Thursday have the potential to upend the multibillion-dollar electronic cigarette industry.
A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.
The new technique could lead to more precise dosing of drugs, including some potentially toxic medicines often delivered in intensive care units.
Researchers have identified a vital supply route that cancer cells use to obtain their nutrients.
The second-biggest U.S. drugmaker on Thursday nudged up its 2016 financial forecasts and its shares edged up in premarket trading.